Cargando…
Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells
To overcome the problem of antitumor agent toxicity for normal cells, a combined therapy using drugs with synergistic effects seems to be more effective. We investigated the molecular mechanisms of the sensitization of tumor cells resistant and sensitive to histone deacetylase inhibitors (HDACis) up...
Autores principales: | Gnedina, Olga O., Morshneva, Alisa V., Igotti, Maria V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650803/ https://www.ncbi.nlm.nih.gov/pubmed/37958894 http://dx.doi.org/10.3390/ijms242115913 |
Ejemplares similares
-
Expression of Adenoviral E1A in Transformed Cells as an Additional Factor of HDACi-Dependent FoxO Regulation
por: Morshneva, Alisa, et al.
Publicado: (2019) -
HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts
por: Gnedina, Olga O., et al.
Publicado: (2022) -
Vimentin, colon cancer progression and resistance to butyrate and other HDACis
por: Lazarova, Darina L., et al.
Publicado: (2016) -
Time-dependent modulation of FoxO activity by HDAC inhibitor in oncogene-transformed E1A+Ras cells
por: Morshneva, Alisa, et al.
Publicado: (2018) -
Correction: Time-dependent modulation of FoxO activity by HDAC inhibitor in oncogene-transformed E1A+Ras cells
por: Morshneva, Alisa, et al.
Publicado: (2018)